EXINI Diagnostics
EXINI Diagnostics AB is a company with over 25 years of experience in developing certified medical device software, specializing in AI methods for automated analysis of diagnostic images. It aims to empower patients for better healthcare through artificial intelligence, with a focus on research, software, and pharma services. The company is committed to quality assurance and collaborates with industry partners to advance medical imaging and cancer treatment.
Industries
Nr. of Employees
small (1-50)
EXINI Diagnostics
Ideon Science Park, Scheelevägen 27, 223 70 Lund, Sweden
Patents
Systems and methods for rapid neural network-based image segmentation and radiopharmaceutical uptake determination
US-12602772-B2
View DetailsSystems and methods for automated identification and classification of lesions in local lymph and distant metastases
US-12597127-B2
View DetailsSystems and methods for automated and interactive analysis of bone scan images for detection of metastases
US-12414748-B2
View Details
Systems and methods for rapid neural network-based image segmentation and radiopharmaceutical uptake determination
US-12602772-B2
View DetailsSystems and methods for automated identification and classification of lesions in local lymph and distant metastases
US-12597127-B2
View DetailsSystems and methods for automated and interactive analysis of bone scan images for detection of metastases
US-12414748-B2
View DetailsProducts
PSMA PET/CT AI analysis software (standardized PSMA reporting)
Deep learning–based software that identifies and quantifies PSMA-avid lesions on PET/CT and produces standardized reports to support prostate cancer assessment and longitudinal tracking.
Automated Bone Scan Index quantification software
Software that automatically computes a Bone Scan Index metric to quantify skeletal tumor burden from planar bone scans and outputs summary metrics for patient management and trials.
Clinical imaging analytics platform for nuclear medicine
A platform offering automated analysis, study review workflows and tools for lesion annotation and measurement to support nuclear medicine imaging across indications (e.g., cardiac, brain, bone, oncology).
PSMA PET/CT AI analysis software (standardized PSMA reporting)
Deep learning–based software that identifies and quantifies PSMA-avid lesions on PET/CT and produces standardized reports to support prostate cancer assessment and longitudinal tracking.
Automated Bone Scan Index quantification software
Software that automatically computes a Bone Scan Index metric to quantify skeletal tumor burden from planar bone scans and outputs summary metrics for patient management and trials.
Clinical imaging analytics platform for nuclear medicine
A platform offering automated analysis, study review workflows and tools for lesion annotation and measurement to support nuclear medicine imaging across indications (e.g., cardiac, brain, bone, oncology).
Services
License and development services to adapt AI imaging algorithms for partner-specific needs and local markets, including model training on partner-provided anonymized datasets.
Provision of imaging analysis services and imaging biomarker development to support early-phase and registrational clinical studies, including standardized quantification and reporting.
Integration services to deploy imaging analysis software on third-party imaging workstations and clinical platforms to fit into existing clinical workflows.
Operational customer and technical support for deployed clinical sites, with designated support hours and contact channels.
Structured process for receiving, investigating and coordinating fixes for security vulnerabilities reported against products.
License and development services to adapt AI imaging algorithms for partner-specific needs and local markets, including model training on partner-provided anonymized datasets.
Provision of imaging analysis services and imaging biomarker development to support early-phase and registrational clinical studies, including standardized quantification and reporting.
Integration services to deploy imaging analysis software on third-party imaging workstations and clinical platforms to fit into existing clinical workflows.
Operational customer and technical support for deployed clinical sites, with designated support hours and contact channels.
Structured process for receiving, investigating and coordinating fixes for security vulnerabilities reported against products.
Expertise Areas
- AI/ML for medical imaging
- Clinical imaging biomarker development
- Regulatory compliance for medical device software (ISO 13485, MDR, FDA QSR)
- PET/CT and nuclear medicine image analytics
Key Technologies
- Deep learning for image analysis
- PSMA PET/CT quantification
- Bone scan quantitative metrics
- PET/CT image processing
News & Updates
EXINI is partnering in the Thera4Care project to leverage AI for personalized cancer treatment, focusing on theranostics and precision oncology.
A new version of aPROMISE for prostate cancer analysis has been released, with new features like updated triangulation and report filtering.
The AI-enabled aPROMISE is now available on Siemens' syngo.via platform and was demonstrated at the SNMMI meeting.
A clinical trial involving INKmune™ and AI quantification of metastatic lesions has been announced.
A new version of PYLARIFY AI® has been released, with features like study review and report improvements.
EXINI is partnering in the Thera4Care project to leverage AI for personalized cancer treatment, focusing on theranostics and precision oncology.
A new version of aPROMISE for prostate cancer analysis has been released, with new features like updated triangulation and report filtering.
The AI-enabled aPROMISE is now available on Siemens' syngo.via platform and was demonstrated at the SNMMI meeting.
A clinical trial involving INKmune™ and AI quantification of metastatic lesions has been announced.
A new version of PYLARIFY AI® has been released, with features like study review and report improvements.